Assessing the Effectiveness of Mass Drug Administration (MDA) With Dihydroartemisinin + Piperaquine for Reducing Malaria Parasite Infection Prevalence and Incidence in Southern Province Zambia
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2017
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- Sponsors PATH
- 20 Sep 2017 Planned End Date changed from 1 Jul 2017 to 1 Mar 2018.
- 20 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.
- 15 Dec 2016 Results published in the Journal of Infectious Diseases